- Open Access
Methylation: a regulator of HIV-1 replication?
Retrovirology volume 4, Article number: 9 (2007)
Recent characterizations of methyl transferases as regulators of cellular processes have spurred investigations into how methylation events might influence the HIV-1 life cycle. Emerging evidence suggests that protein-methylation can positively and negatively regulate HIV-1 replication. How DNA- and RNA- methylation might impact HIV-1 is also discussed.
Biologically, methylation is executed by discrete enzymes (methyltransferases) which recognize DNA, RNA and proteins. Methylation of DNA, RNA or protein can regulate gene expression, RNA metabolism, and protein activity. Recently, protein methylation has stepped into the lime light due to the identification and characterization of protein arginine methyltransferases (PRMTs) which catalyze additions to arginine residues. PRMTs transfer one or two methyl groups from S-adenosylmethinine (SAM) to the guanidine-nitrogen atoms in arginine, forming methylarginine and/or S-adenosylhomocysteine . PRMTs are ubiquitously expressed in cells; however, much is unknown about their regulated expression and stability .
Arginine methylation impacts cellular processes ranging from transcription, RNA processing, and cell signaling. PRMTs can function as transcriptional co-activators through remodeling chromatin and modifying histone tails. Methylation of histone H3 and H4 by CARM1 and PRMT1 is thought to contribute to a histone code [3, 4] which programs gene expression. PRMTs also methylate non-histone proteins, such as CBP, to modulate co-activator function [5, 6]. RNA binding proteins (RBPs) such as hnRNPs, Sam68, and Sm complex also have arginine-glycine repeats, a motif recognized and methylated by PRMTs. Methylation of RBPs may dictate activity as evidenced by findings that Sam68 and snRNPs require methyl addition to localize properly in the nucleus and assemble into appropriate multi-molecular complexes [7, 8].
Emerging evidence implicates methylation in regulated HIV-1 replication [9–12]. Now two new reports in Retrovirology [13, 14] add to our understanding of how methylation could influence HIV-1 biology. In the first, Willemsen et al. used HIV-1 infected CEM T-cells and provirus transfected HEK293T cells to link protein methylation to virion infectivity. They employed adenosine periodate (AdOx), a general inhibitor of many methyltransferases, to address the effect of methylation on HIV-1 in tissue culture. Willemsen et al. found that AdOx treatment increased virus production from both adherent cells transfected with a proviral molecular clone and T-cells infected with HIV-1. Interestingly, the authors saw decreased p24 levels in infected CEM T-cells treated with AdOx, which was accompanied by substantially increased p24 amounts in the culture supernatants. This provocative observation suggests that methylation may regulate the processing and/or assembly of HIV-1 Gag protein. This interpretation makes sense because they also saw differences in the composition and size of virions produced in the presence or absence of AdOx, a finding consistent with perturbed virion assembly when methylation events are inhibited. Finally, AdOx treatment was found to significantly decrease HIV-1 infectivity; however, this decreased infectivity was overcome when HIV-1 virions were pseudotyped with VSV-G protein. The latter result invokes a methylation step in either HIV-1 envelope-receptor binding and/or virus envelope-uncoating in newly infected cells (Fig. 1).
In the second article, Invernizzi et al. described the novel methylation in HIV-1 Rev's arginine-rich motif by PRMT6. Here, they reported that PRMT6 binds Rev and decreases the stability of Rev in cells (Fig. 1). Additionally, methylated Rev bound the RRE (Rev responsive element in HIV-1 RNAs ) poorly and was associated with an attenuated Rev-RRE-dependent export of viral transcripts from the nucleus to cytoplasm. Thus, methylation in this context of HIV-1 infection provides a negative influence.
Collectively, the two new articles extend the emerging notion for methylation regulating HIV-1 biology. While the activity described by Invernizzi et al. stems clearly from PRMT6 methylation of Rev, the results accrued by Willemsen et al. paint a less clear mechanistic picture. Willemsen et al. used a broadly non-specific inhibitor of methylation, AdOx. AdOx is a competitive inhibitor of all SAM dependent methylation which includes protein-, RNA-, and DNA- modifications. Hence, the findings from Willemsen et al. while suggestive of an effect involving HIV-1 envelope cannot formally exclude contributions from Adox's action on unidentified RNA- or DNA- methylation.
So where do these reports lead us? The HIV-1 genome contains 9 open reading frames which can encode 15 proteins, and virus replication involves a complex interplay between viral and cellular proteins. What remains to be deciphered is the relative contribution of methylation on virus-factors versus cellular macromolecules. In this regard, Kwak et al.  have reported earlier that inhibition of arginine-methylation can also influence HIV-1 transcription. They showed that cellular transcription elongation protein SPT5 is a substrate of protein arginine methyltransferases PRMT1 and PRMT5, and that methylated SPT5 is less able to associate with RNA polymerase II and to assist Tat in efficient elongation of HIV-1 LTR-directed transcription.
Besides protein-methylation, there is compelling evidence that DNA-methylation influences HIV-1 replication. CpG methylation of LTR DNA has been reported to promote viral latency [16–19]. Some of these effects are explained by DNA-methylation impeding the binding of Sp1 and NF-κB transcription factors to the LTR promoter [20, 21]. Indeed, activation of viral expression from latently infected cells does appear to correlate with loss of methylation of the HIV-1 LTR DNA.
Finally, what about RNA-methylation? RNA methyl modifications are involved in functional maturation of many species of cellular RNAs including mRNA, rRNA, tRNA, snRNA and snoRNA. Methylation of the RNA cap (7-methylguanosine cap) is a critical processing step for cellular and viral mRNAs. This action increases mRNA stability and promotes efficient export and translation. Other cap methyl modifications (e.g., hypermethylation – 2,2,7-trimethylguanosine modification of mRNA caps) have been identified in Oncorna viruses, Reo viruses, Sindbis virus, and Caenorhabditis elegans mRNAs [22–25]. The significance of these modifications remains undetermined. We have also recently identified a cellular RNA methyltransferase whose activity appears to upregulate HIV-1 gene expression (unpublished). Going forward, a better understanding of the varying complexities of methylation and their myriad effects on virus replication may unveil these processes as useful novel drug targets for HIV-1.
Gary JD, Clarke S: RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol. 1998, 61: 65-131.
Bedford MT, Richard S: Arginine methylation an emerging regulator of protein function. Mol Cell. 2005, 18: 263-272. 10.1016/j.molcel.2005.04.003.
McBride AE, Silver PA: State of the arg: protein methylation at arginine comes of age. Cell. 2001, 106: 5-8. 10.1016/S0092-8674(01)00423-8.
Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S: Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol Cell Biol. 2004, 24: 9630-9645. 10.1128/MCB.24.21.9630-9645.2004.
Xu W, Chen H, Du K, Asahara H, Tini M, Emerson BM, Montminy M, Evans RM: A transcriptional switch mediated by cofactor methylation. Science. 2001, 294: 2507-2511. 10.1126/science.1065961.
Chevillard-Briet M, Trouche D, Vandel L: Control of CBP co-activating activity by arginine methylation. EMBO J. 2002, 21: 5457-5466. 10.1093/emboj/cdf548.
Cote J, Boisvert FM, Boulanger MC, Bedford MT, Richard S: Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol Biol Cell. 2003, 14: 274-287. 10.1091/mbc.E02-08-0484.
Brahms H, Meheus L, de B, Fischer U, Luhrmann R: Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA. 2001, 7: 1531-1542. 10.1017/S135583820101442X.
Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, Wainberg MA, Richard S: Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol. 2005, 79: 124-131. 10.1128/JVI.79.1.124-131.2005.
Ishida T, Hamano A, Koiwa T, Watanabe T: 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology. 2006, 3: 69-10.1186/1742-4690-3-69.
Tanaka J, Ishida T, Choi BI, Yasuda J, Watanabe T, Iwakura Y: Latent HIV-1 reactivation in transgenic mice requires cell cycle -dependent demethylation of CREB/ATF sites in the LTR. AIDS. 2003, 17: 167-175. 10.1097/00002030-200301240-00005.
Kwak YT, Guo J, Prajapati S, Park KJ, Surabhi RM, Miller B, Gehrig P, Gaynor RB: Methylation of SPT5 regulates its interaction with RNA polymerase II and transcriptional elongation properties. Mol Cell. 2003, 11: 1055-1066. 10.1016/S1097-2765(03)00101-1.
Willemsen NM, Hitchen EM, Bodetti TJ, Apolloni A, Warrilow D, Piller SC, Harrich D: Protein methylation is required to maintain optimal HIV-1 infectivity. Retrovirology. 2006, 3: 92-10.1186/1742-4690-3-92.
Invernizzi CF, Xie B, Richard S, Wainberg MA: PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA. Retrovirology. 2006, 3: 93-10.1186/1742-4690-3-93.
Dayton AI: Within you, without you: HIV-1 Rev and RNA export. Retrovirology. 2004, 1: 35-10.1186/1742-4690-1-35.
Bednarik DP, Mosca JD, Raj NB: Methylation as a modulator of expression of human immunodeficiency virus. J Virol. 1987, 61: 1253-1257.
Bednarik DP, Cook JA, Pitha PM: Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency. EMBO J. 1990, 9: 1157-1164.
Gutekunst KA, Kashanchi F, Brady JN, Bednarik DP: Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation. J Acquir Immune Defic Syndr. 1993, 6: 541-549.
Schulze-Forster K, Gotz F, Wagner H, Kroger H, Simon D: Transcription of HIV1 is inhibited by DNA methylation. Biochem Biophys Res Commun. 1990, 168: 141-147. 10.1016/0006-291X(90)91685-L.
Mancini DN, Singh SM, Archer TK, Rodenhiser DI: Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene. 1999, 18: 4108-4119. 10.1038/sj.onc.1202764.
Bednarik DP, Duckett C, Kim SU, Perez VL, Griffis K, Guenthner PC, Folks TM: DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs. New Biol. 1991, 3: 969-976.
Stoltzfus CM, Dimock K: Evidence of methylation of B77 avian sarcoma virus genome RNA subunits. J Virol. 1976, 18: 586-595.
Faust M, Hastings KE, Millward S: m7G5'ppp5'GmptcpUp at the 5' terminus of reovirus messenger RNA. Nucleic Acids Res. 1975, 2: 1329-1343. 10.1093/nar/2.8.1329.
HsuChen CC, Dubin DT: Di-and trimethylated congeners of 7-methylguanine in Sindbis virus mRNA. Nature. 1976, 264: 190-191. 10.1038/264190a0.
Liou RF, Blumenthal T: trans-spliced Caenorhabditis elegans mRNAs retain trimethylguanosine caps. Mol Cell Biol. 1990, 10: 1764-1768.
We thank Dr. Andrew Dayton for a critical reading of this manuscript.
The author(s) declare that they have no competing interests.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Yedavalli, V.R., Jeang, K. Methylation: a regulator of HIV-1 replication?. Retrovirology 4, 9 (2007) doi:10.1186/1742-4690-4-9
- Methyl Modification
- Protein Arginine Methyltransferases
- AdOx Treatment
- Protein SPT5
- Modify Histone Tail